Cystectomy Humans Male Prostate *Prostatic Hyperplasia/surgery *Transurethral Resection of Prostate Treatment Outcome *Urinary Bladder Neoplasms/surgery Bladder cancer benign prostatic hypertrophy prostate cancer transurethral resection

Humans Smoking/adverse effects/epidemiology *Non-Muscle Invasive Bladder Neoplasms *Urinary Bladder Neoplasms/epidemiology/etiology *Carcinoma Transitional Cell Prognosis Neoplasm Recurrence Local/epidemiology Current smoker Non-muscle-invasive bladder cancer Progression Recurrence Smoking

Humans Female *Urinary Bladder Neoplasms/pathology *Carcinoma Transitional Cell/pathology Urinary Bladder/pathology Prognosis Proportional Hazards Models Meta-analysis Muscle-invasive bladder urothelial carcinoma Non-muscle-invasive bladder urothelial carcinoma Sex

Humans Immune Checkpoint Inhibitors/therapeutic use *Carcinoma Transitional Cell/drug therapy *Urinary Bladder Neoplasms/drug therapy Proportional Hazards Models Eastern Cooperative Oncology Group Immune checkpoint inhibitor Performance status Urothelial carcinoma

Humans *Carcinoma Transitional Cell/drug therapy *Urinary Bladder Neoplasms/pathology *Urologic Neoplasms/drug therapy/pathology Antibodies Monoclonal/adverse effects

Humans Aged Cystectomy/methods *Urinary Bladder Neoplasms/surgery Urinary Bladder *Urinary Diversion/methods Hospital Mortality Bladder cancer Complications Epidemiology Mortality Radical cystectomy Urinary diversions

Humans *Urinary Bladder Neoplasms *Carcinoma Transitional Cell/surgery/pathology Ureteroscopy/adverse effects/methods *Ureteral Neoplasms/surgery/pathology *Kidney Neoplasms/surgery/pathology Antegrade Endoscopic surgery Kidney-sparing surgery Retrograde Upper tract urothelial carcinoma

Male Humans *Stomach Neoplasms/genetics *Urinary Bladder Neoplasms/genetics Urinary Bladder Membrane Proteins RNA Messenger Antigens Neoplasm/genetics Neoplasm Proteins GPI-Linked Proteins/genetics Psca cancer risk polymorphism rs2294008 (C/T)

Humans *Transurethral Resection of Bladder Neoplasm Recurrence Local/pathology *Urinary Bladder Neoplasms/diagnosis/surgery/pathology Prognosis Urologic Surgical Procedures Cystectomy Bladder cancer Css Os Pfs Rfs Transurethral resection of bladder tumors financial ties to disclose.

Humans *Urinary Diversion/adverse effects *Ureter/surgery Cystectomy/methods Anastomosis Surgical/adverse effects *Vesico-Ureteral Reflux/etiology *Urinary Bladder Neoplasms/surgery Ileum/surgery *Pyelonephritis/complications Bladder Orthotopic ileal neobladder Radical cystectomy Tumor Ureteroenteric anastomosis Urinary diversion

Humans *Carcinoma Transitional Cell/pathology *Urinary Bladder Neoplasms/genetics DNA Methylation Neoplasm Recurrence Local/genetics Prognosis *Urologic Neoplasms/genetics/pathology Membrane Proteins/genetics Neoplasm Proteins/genetics Biomarkers Kaplan-Meier survival Meta-analysis Methylation Upper tract urothelial carcinoma

Humans *Gemcitabine Docetaxel/therapeutic use BCG Vaccine/adverse effects Adjuvants Immunologic *Urinary Bladder Neoplasms/therapy Administration Intravesical Neoplasm Invasiveness Neoplasm Recurrence Local

Humans *BCG Vaccine/adverse effects *Urinary Bladder Neoplasms/drug therapy BCG vaccine administration intravesical systematic review urinary bladder neoplasms

Humans Cystectomy/adverse effects/methods *Urinary Bladder Neoplasms/surgery/etiology Urinary Bladder *Urinary Diversion/adverse effects/methods *Acidosis/epidemiology/etiology/therapy Acidosis metabólica Bicarbonate Bicarbonato Bladder tumor Cistectomía radical Derivación urinaria Metabolic acidosis Radical cystectomy Tratamiento Treatment Tumor vesical Urinary diversion

Adult Humans Cystectomy/adverse effects Quality of Life *Robotic Surgical Procedures/methods Treatment Outcome Postoperative Complications/etiology *Urinary Bladder Neoplasms/surgery/complications

Humans *Adjuvants Immunologic/therapeutic use/adverse effects Administration Intravesical Neoplasm Recurrence Local/epidemiology *Urinary Bladder Neoplasms/pathology Drug Administration Schedule Bcg Cvnmi Desabastecimiento Dosis completa Dosis reducida Full dose Nmibc Reduced dose Shortage

Humans Cystectomy/adverse effects Prospective Studies Quality of Life *Robotics Treatment Outcome *Robotic Surgical Procedures/adverse effects Postoperative Complications/etiology *Urinary Bladder Neoplasms/pathology

Humans *Urinary Bladder Neoplasms/surgery/pathology Urologic Surgical Procedures Cystectomy *Laser Therapy *Lasers Solid-State/therapeutic use Turbt bladder tumor laser resection recurrence

Humans Photosensitizing Agents/therapeutic use Neoplasm Residual Neoplasm Recurrence Local/prevention & control *Photochemotherapy/methods Randomized Controlled Trials as Topic *Urinary Bladder Neoplasms/drug therapy/surgery/diagnosis Aminolevulinic Acid/therapeutic use Cystoscopy/methods Cystoscopy Fluorescent cystoscopy Hexaminolevulinate Meta-analysis Nonmuscle invasive bladder cancer Urinary bladder neoplasms conflicts of interest in the manuscript and during the submission process. This manuscript has not been published and is not under consideration for publication elsewhere.

Humans Mitomycin Gemcitabine Hematuria *Non-Muscle Invasive Bladder Neoplasms Deoxycytidine/therapeutic use Administration Intravesical *Urinary Bladder Neoplasms/drug therapy *Cystitis Chemical cystitis Cistitis química Cáncer de vejiga sin invasión muscular Gemcitabina intravesical Intravesical gemcitabine Intravesical mitomycin Mitomicina intravesical Non-muscle invasive bladder cancer Recurrence rates Tasas de recurrencia